WEST PHARM.SVCS DL-,25/ US9553061055 /
29/08/2024 08:14:56 | Chg. -1.10 | Volume | Bid21:59:53 | Ask21:59:53 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
270.00EUR | -0.41% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 20.61 bill.EUR | - | - |
Assets
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 705.8000 | 721 | 778.3000 | 855 | 822 | ||||||
Intangible Assets | 42 | 37.6000 | 23.3000 | 21.7000 | 20.3000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 1,011.6000 | 1,021.4000 | 1,074.8000 | 1,119.3000 | 1,084.5000 | ||||||
Inventories | 181.5000 | 181.1000 | 199.3000 | 215.2000 | 214.5000 | ||||||
Accounts Receivable | 179 | 181.4000 | 200.5000 | 253.2000 | 288.2000 | ||||||
Cash and Cash Equivalents | 255.3000 | 274.6000 | 203 | 235.9000 | 337.4000 | ||||||
Current Assets | 659.3000 | 673.7000 | 641.9000 | 743.5000 | 894.4000 | ||||||
Total Assets | 1,670.9000 | 1,695.1000 | 1,716.7000 | 1,862.8000 | 1,978.9000 |
Liabilities
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 103.1000 | 119.8000 | 122 | 138.1000 | 130.4000 | ||||||
Long-term debt | 309.5000 | 228.9000 | 226.2000 | 197 | 196 | ||||||
Liabilities to Banks | 27.2000 | 69.3000 | 2.4000 | 0.0000 | .1000 | ||||||
Provisions | 30.6000 | 25.2000 | 13.7000 | 16.4000 | 22.9000 | ||||||
Liabilities | 714 | 671.2000 | 599.2000 | 582.9000 | 582.6000 | ||||||
Share Capital | 17.8000 | 18.1000 | 18.4000 | 18.8000 | 18.8000 | ||||||
Total Equity | 956.9000 | 1,023.9000 | 1,117.5000 | 1,279.9000 | 1,396.3000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 1,670.9000 | 1,695.1000 | 1,716.7000 | 1,862.8000 | 1,978.9000 |
Income Statement
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,368.4000 | 1,399.8000 | 1,509.1000 | 1,599.1000 | 1,717.4000 | ||||||
Depreciation (total) | 81 | 86.1000 | - | - | - | ||||||
Operating Result | 162.4000 | 128.6000 | 196.8000 | 228.9000 | 240.3000 | ||||||
Interest Income | 17 | 14.1000 | 8.1000 | 7.8000 | 8.4000 | ||||||
Income Before Taxes | 147.1000 | 116.1000 | 189.8000 | 222.4000 | 240.7000 | ||||||
Income Taxes | 40.2000 | 26.3000 | 54.4000 | 80.9000 | 41.4000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 112.3000 | 95.6000 | 143.6000 | 150.7000 | 206.9000 |
Per Share
Cash Flow
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 220.5000 | 212.4000 | 219.4000 | 263.3000 | 288.6000 | ||||||
Cash Flow from Investing Activities | -149.9000 | -129.5000 | -175.8000 | -133.6000 | -100.8000 | ||||||
Cash Flow from Financing | -5.1000 | -41.5000 | -113.9000 | -109 | -80.7000 | ||||||
Decrease / Increase in Cash | 68.1000 | 19.3000 | -71.6000 | 32.9000 | 101.5000 | ||||||
Employees | 7,000 | 7,100 | 7,300 | 7,500 | 7,700 |